Work

POSTER: MPN-404 Safety and Efficacy of Luspatercept for the Treatment of Anemia in Patients With Myelofibrosis: Results From the ACE-536-MF-001 Study

Year: 2023
Type: article
Institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, Stanford Cancer Institute, O'Neal Comprehensive Cancer Center, Stanford University, Guy's and St Thomas' NHS Foundation Trust, Heidelberg University, Fred Hutch Cancer Center, The Christie NHS Foundation Trust, Cancer Research UK Manchester Institute, Hôpital Saint-Louis, Institut Gustave Roussy, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, CTI BioPharma (United States), Mays Cancer Center at UT Health San Antonio, Wake Forest University Health Sciences, Wake Forest University, University of Bologna, University of Utah, Moffitt Cancer Center, Wroclaw Medical University, Hospital Universitario 12 De Octubre, Azienda Ospedaliero-Universitaria Careggi, University of Florence, ARUP Laboratories (United States), Universitätsklinikum Aachen, Monash University, RWTH Aachen University, University of Milan, Mount Sinai Hospital, Hadassah Medical Center, Leipzig University, Fujita Health University, National Institute for Health and Care Research, University of Oxford, NIHR Oxford Biomedical Research Centre, MRC Weatherall Institute of Molecular Medicine, AbbVie (United States), Gdańsk Medical University, Hôpital Necker-Enfants Malades, Inserm, Dana-Farber Cancer Institute, Institut des Maladies Génétiques Imagine, Bristol-Myers Squibb (Switzerland), Oslo University Hospital, Bristol-Myers Squibb (United States), Mayo Clinic Hospital, Abramson Cancer Center, University of Pennsylvania, University Medical Center Groningen, University of Tennessee Medical Center
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4386270955
FWCI:
Cites:
Cited by:
Related to: 10